Status:
COMPLETED
The Duration of Humoral Immunity and the Memory Cell Function After Vaccination With 7-valent Pneumococcal Conjugate Vaccine in CLL
Lead Sponsor:
Tampere University Hospital
Collaborating Sponsors:
Turku University Hospital
Finnish Institute for Health and Welfare
Conditions:
Chronic Lymphocytic Leukemia (CLL)
Eligibility:
All Genders
45-90 years
Phase:
PHASE4
Brief Summary
Patients with chronic lymphocytic leukemia (CLL)have had very poor humoral responses to pneumococcal polysaccharide vaccine (PPV). The vaccine in which pneumococcal polysaccharide antigens are conjuga...
Eligibility Criteria
Inclusion
- CLL patients and controls who have been vaccinated with PCV in our previous study
Exclusion
- Vaccinated with PPV-vaccine within the last 5 years, immunoglobulin substitution, corticosteroid treatment (equivalent of 20mg prednisolone per day)
Key Trial Info
Start Date :
June 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT00919321
Start Date
June 1 2009
End Date
December 1 2013
Last Update
February 19 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tampere University Hospital
Tampere, Pirkanmaa, Finland, FIN 33521